データなし
コード銘柄名
現在値変化額変化率出来高売買代金始値前日終値高値安値時価総額浮動株時価株式総数浮動株5日変化率10日変化率20日変化率60日変化率120日変化率250日変化率年初来配当利回売買回転率直近PER前年PER振幅業種
お気に入り
米国オプション銘柄情報
HRTX241115C1500
- 0.32
- -0.03-8.57%
15分遅延終値 11/05 16:00 ET
0.32高値0.32安値
0.32始値0.35前日終値7枚出来高120枚未決済建玉1.50行使価格224.00売買代金137.13%予想変動率2.82%プレミアム2024/11/15満期日0.27本質的価値100倍率10日満期まで0.05時間価値100サイズ米国タイプ0.8039デルタ0.6972ガンマ5.53てこ-0.0058Theta0.0003Rho4.45実効てこ0.0008ベガ
日中
- 5日
- 日足
ニュース
Positive Signs As Multiple Insiders Buy Heron Therapeutics Stock
Heron Therapeutics Announces Appointment of Michael Kaseta to Board of Directors
Heron Therapeutics to Report Third Quarter 2024 Financial Results On Tuesday, November 12, 2024
Heron Therapeutics Reaffirms Treatment Supply After Hurricane Helene
Heron Therapeutics: Marion Facility Is Believed to Supply Up to 60% of the IV Fluid Market in U.S. >HRTX
Heron Therapeutics: CINVANTI, in Combination With Other Antiemetic Agents, Is Indicated in Adults for Prevention of Nausea and Vomiting Associated With Cancer Chemotherapy >HRTX